Strojil J - Search Results

1

Gut microbiota metabolizes nabumetone in vitro: Consequences for its bioavailability in vivo in the rodents with altered gut microbiome.

Jourova L, Anzenbacher P, Matuskova Z, Vecera R, Strojil J, Kolar M, Nobilis M, Hermanova P, Hudcovic T, Kozakova H, Kverka M, Anzenbacherova E. Jourova L, et al. Among authors: strojil j. Xenobiotica. 2019 Nov;49(11):1296-1302. doi: 10.1080/00498254.2018.1558310. Epub 2019 Feb 22. Xenobiotica. 2019. PMID: 30794062

2

Effect of Lactobacillus casei on the Pharmacokinetics of Amiodarone in Male Wistar Rats.

Matuskova Z, Anzenbacher P, Vecera R, Siller M, Tlaskalova-Hogenova H, Strojil J, Anzenbacherova E. Matuskova Z, et al. Among authors: strojil j. Eur J Drug Metab Pharmacokinet. 2017 Feb;42(1):29-36. doi: 10.1007/s13318-015-0315-0. Eur J Drug Metab Pharmacokinet. 2017. PMID: 26797809

3

Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat.

Večeřa R, Zachařová A, Orolin J, Strojil J, Skottová N, Anzenbacher P. Večeřa R, et al. Among authors: strojil j. Biopharm Drug Dispos. 2011 Nov;32(8):482-7. doi: 10.1002/bdd.774. Epub 2011 Oct 4. Biopharm Drug Dispos. 2011. PMID: 21968795

4

Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.

Urbánek K, Kolár M, Strojil J, Koukalová D, Cekanová L, Hejnar P. Urbánek K, et al. Among authors: strojil j. Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):741-5. doi: 10.1002/pds.1110. Pharmacoepidemiol Drug Saf. 2005. PMID: 15880441

5

Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains.

Urbánek K, Kolár M, Lovecková Y, Strojil J, Santavá L. Urbánek K, et al. Among authors: strojil j. J Clin Pharm Ther. 2007 Aug;32(4):403-8. doi: 10.1111/j.1365-2710.2007.00836.x. J Clin Pharm Ther. 2007. PMID: 17635342

6

Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: a comparison of 0.5-h and 3-h infusions.

Lipš M, Siller M, Strojil J, Urbánek K, Balík M, Suchánková H. Lipš M, et al. Among authors: strojil j. Int J Antimicrob Agents. 2014 Oct;44(4):358-62. doi: 10.1016/j.ijantimicag.2014.05.011. Epub 2014 Jun 25. Int J Antimicrob Agents. 2014. PMID: 25216543 Clinical Trial.

7

Is continuous infusion of imipenem always the best choice?

Suchánková H, Lipš M, Urbánek K, Neely MN, Strojil J. Suchánková H, et al. Among authors: strojil j. Int J Antimicrob Agents. 2017 Mar;49(3):348-354. doi: 10.1016/j.ijantimicag.2016.12.005. Epub 2017 Feb 9. Int J Antimicrob Agents. 2017. PMID: 28189734

8

Individualized dosing of vancomycin in geriatric patients.

Suchánková H, Lečbychová K, Strojil J, Fürst T. Suchánková H, et al. Among authors: strojil j. Epidemiol Mikrobiol Imunol. 2020 Winter;69(4):172-180. Epidemiol Mikrobiol Imunol. 2020. PMID: 33445941 English.

9

Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients.

de Velde F, de Winter BCM, Neely MN, Strojil J, Yamada WM, Harbarth S, Huttner A, van Gelder T, Koch BCP, Muller AE, On Behalf Of The Combacte-Net Consortium. de Velde F, et al. Among authors: strojil j. Pharmaceutics. 2021 Dec 16;13(12):2170. doi: 10.3390/pharmaceutics13122170. Pharmaceutics. 2021. PMID: 34959451 Free PMC article.

10

Lessons for teaching from the pandemic.

Strojil J, Suchánková H. Strojil J, et al. Br J Clin Pharmacol. 2023 Jan;89(1):43-45. doi: 10.1111/bcp.14529. Epub 2020 Sep 2. Br J Clin Pharmacol. 2023. PMID: 32839969 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page